Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 9 February 2018

Gene and cell therapy headlines 2 - 9 February

Second patient undergoes in vivo gene editing as no adverse effects experienced by first patient

 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us